GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Yy1
|
ENSMUSG00000021264.11 | YY1 transcription factor |
Yy2
|
ENSMUSG00000091736.2 | Yy2 transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Yy2 | mm10_v2_chrX_-_157598642_157598655 | -0.41 | 1.2e-02 | Click! |
Yy1 | mm10_v2_chr12_+_108792946_108792988 | -0.26 | 1.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_69284982 | 9.10 |
ENSMUST00000183882.1
ENSMUST00000037064.4 |
Slc25a37
|
solute carrier family 25, member 37 |
chr5_-_134915512 | 8.03 |
ENSMUST00000008987.4
|
Cldn13
|
claudin 13 |
chr13_-_21753851 | 7.22 |
ENSMUST00000074752.2
|
Hist1h2ak
|
histone cluster 1, H2ak |
chr13_-_23551648 | 6.74 |
ENSMUST00000102971.1
|
Hist1h4f
|
histone cluster 1, H4f |
chr8_-_121907678 | 6.42 |
ENSMUST00000045557.9
|
Slc7a5
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 |
chr4_-_46404224 | 5.97 |
ENSMUST00000107764.2
|
Hemgn
|
hemogen |
chr11_+_117849286 | 5.55 |
ENSMUST00000093906.4
|
Birc5
|
baculoviral IAP repeat-containing 5 |
chr15_-_103252810 | 5.52 |
ENSMUST00000154510.1
|
Nfe2
|
nuclear factor, erythroid derived 2 |
chr10_+_43579161 | 5.51 |
ENSMUST00000058714.8
|
Cd24a
|
CD24a antigen |
chr7_-_103843154 | 5.49 |
ENSMUST00000063957.4
|
Hbb-bh1
|
hemoglobin Z, beta-like embryonic chain |
chr7_+_35802593 | 5.34 |
ENSMUST00000052454.2
|
E130304I02Rik
|
RIKEN cDNA E130304I02 gene |
chr12_+_109459843 | 5.28 |
ENSMUST00000173812.1
|
Dlk1
|
delta-like 1 homolog (Drosophila) |
chr6_+_86628174 | 5.05 |
ENSMUST00000043400.6
|
Asprv1
|
aspartic peptidase, retroviral-like 1 |
chr13_+_23535411 | 4.95 |
ENSMUST00000080859.5
|
Hist1h3g
|
histone cluster 1, H3g |
chr8_+_84856982 | 4.86 |
ENSMUST00000003906.6
ENSMUST00000109754.1 |
Farsa
|
phenylalanyl-tRNA synthetase, alpha subunit |
chr3_-_90695706 | 4.83 |
ENSMUST00000069960.5
ENSMUST00000117167.1 |
S100a9
|
S100 calcium binding protein A9 (calgranulin B) |
chr2_-_150668198 | 4.72 |
ENSMUST00000028944.3
|
Acss1
|
acyl-CoA synthetase short-chain family member 1 |
chr3_-_90213577 | 4.65 |
ENSMUST00000170122.2
|
Rps27
|
ribosomal protein S27 |
chr19_-_50030735 | 4.63 |
ENSMUST00000071866.1
|
Rpl13a-ps1
|
ribosomal protein 13A, pseudogene 1 |
chr3_+_90669063 | 4.62 |
ENSMUST00000069927.8
|
S100a8
|
S100 calcium binding protein A8 (calgranulin A) |
chr17_-_23829095 | 4.62 |
ENSMUST00000069579.5
|
Tceb2
|
transcription elongation factor B (SIII), polypeptide 2 |
chr17_-_35066170 | 4.55 |
ENSMUST00000174190.1
ENSMUST00000097337.1 |
AU023871
|
expressed sequence AU023871 |
chr4_+_108579445 | 4.53 |
ENSMUST00000102744.3
|
Orc1
|
origin recognition complex, subunit 1 |
chr13_+_21722057 | 4.42 |
ENSMUST00000110476.3
|
Hist1h2bm
|
histone cluster 1, H2bm |
chr11_+_32286946 | 4.38 |
ENSMUST00000101387.3
|
Hbq1b
|
hemoglobin, theta 1B |
chr14_-_69503316 | 4.37 |
ENSMUST00000179116.2
|
Gm21464
|
predicted gene, 21464 |
chr10_-_128549102 | 4.36 |
ENSMUST00000176906.1
|
Rpl41
|
ribosomal protein L41 |
chr7_-_103813913 | 4.32 |
ENSMUST00000098192.3
|
Hbb-bt
|
hemoglobin, beta adult t chain |
chr8_-_107263248 | 4.32 |
ENSMUST00000080443.6
|
Rps18-ps3
|
ribosomal protein S18, pseudogene 3 |
chr10_+_14523062 | 4.29 |
ENSMUST00000096020.5
|
Gm10335
|
predicted gene 10335 |
chr19_-_11640828 | 4.20 |
ENSMUST00000112984.2
|
Ms4a3
|
membrane-spanning 4-domains, subfamily A, member 3 |
chr10_-_128549125 | 4.20 |
ENSMUST00000177163.1
ENSMUST00000176683.1 ENSMUST00000176010.1 |
Rpl41
|
ribosomal protein L41 |
chr11_-_102469839 | 4.14 |
ENSMUST00000103086.3
|
Itga2b
|
integrin alpha 2b |
chr18_+_56707725 | 4.12 |
ENSMUST00000025486.8
|
Lmnb1
|
lamin B1 |
chr1_-_89933290 | 4.11 |
ENSMUST00000036954.7
|
Gbx2
|
gastrulation brain homeobox 2 |
chr11_+_62248977 | 4.11 |
ENSMUST00000018644.2
|
Adora2b
|
adenosine A2b receptor |
chr9_+_21029373 | 4.11 |
ENSMUST00000001040.5
|
Icam4
|
intercellular adhesion molecule 4, Landsteiner-Wiener blood group |
chr3_-_130730375 | 4.09 |
ENSMUST00000079085.6
|
Rpl34
|
ribosomal protein L34 |
chr13_+_21811737 | 4.05 |
ENSMUST00000104941.2
|
Hist1h4m
|
histone cluster 1, H4m |
chr14_-_43819639 | 3.97 |
ENSMUST00000100691.3
|
Ear1
|
eosinophil-associated, ribonuclease A family, member 1 |
chr6_-_83054415 | 3.94 |
ENSMUST00000113962.1
ENSMUST00000089645.6 ENSMUST00000113963.1 |
Htra2
|
HtrA serine peptidase 2 |
chr7_+_24862193 | 3.94 |
ENSMUST00000052897.4
ENSMUST00000170837.2 |
Gm9844
Gm9844
|
predicted pseudogene 9844 predicted pseudogene 9844 |
chr10_+_79886302 | 3.92 |
ENSMUST00000046091.5
|
Elane
|
elastase, neutrophil expressed |
chr12_-_87444017 | 3.86 |
ENSMUST00000091090.4
|
2700073G19Rik
|
RIKEN cDNA 2700073G19 gene |
chr18_+_34840575 | 3.84 |
ENSMUST00000043484.7
|
Reep2
|
receptor accessory protein 2 |
chr14_+_31134853 | 3.81 |
ENSMUST00000090212.4
|
Nt5dc2
|
5'-nucleotidase domain containing 2 |
chr2_+_30416096 | 3.80 |
ENSMUST00000113601.3
ENSMUST00000113603.3 |
Ppp2r4
|
protein phosphatase 2A, regulatory subunit B (PR 53) |
chr7_+_78914216 | 3.80 |
ENSMUST00000120331.2
|
Isg20
|
interferon-stimulated protein |
chr11_+_32276893 | 3.80 |
ENSMUST00000145569.1
|
Hba-x
|
hemoglobin X, alpha-like embryonic chain in Hba complex |
chr14_-_18270953 | 3.79 |
ENSMUST00000100799.2
ENSMUST00000079419.4 ENSMUST00000080281.7 |
Rpl15
|
ribosomal protein L15 |
chrX_+_8271642 | 3.78 |
ENSMUST00000115590.1
|
Slc38a5
|
solute carrier family 38, member 5 |
chr13_-_23745511 | 3.77 |
ENSMUST00000091752.2
|
Hist1h3c
|
histone cluster 1, H3c |
chr14_-_69503220 | 3.75 |
ENSMUST00000180059.2
|
Gm21464
|
predicted gene, 21464 |
chr7_+_103937382 | 3.71 |
ENSMUST00000098189.1
|
Olfr632
|
olfactory receptor 632 |
chr9_-_70421533 | 3.69 |
ENSMUST00000034742.6
|
Ccnb2
|
cyclin B2 |
chr15_-_103255433 | 3.68 |
ENSMUST00000075192.6
|
Nfe2
|
nuclear factor, erythroid derived 2 |
chrX_+_48146436 | 3.67 |
ENSMUST00000033427.6
|
Sash3
|
SAM and SH3 domain containing 3 |
chr17_+_48359891 | 3.65 |
ENSMUST00000024792.6
|
Treml1
|
triggering receptor expressed on myeloid cells-like 1 |
chr14_-_70627008 | 3.65 |
ENSMUST00000110984.2
|
Dmtn
|
dematin actin binding protein |
chr17_+_29135056 | 3.64 |
ENSMUST00000087942.4
|
Rab44
|
RAB44, member RAS oncogene family |
chr2_+_164769892 | 3.64 |
ENSMUST00000088248.6
ENSMUST00000001439.6 |
Ube2c
|
ubiquitin-conjugating enzyme E2C |
chr7_-_126704179 | 3.64 |
ENSMUST00000106364.1
|
Coro1a
|
coronin, actin binding protein 1A |
chr10_+_80855275 | 3.64 |
ENSMUST00000035597.8
|
Sppl2b
|
signal peptide peptidase like 2B |
chr7_-_103827922 | 3.63 |
ENSMUST00000023934.6
ENSMUST00000153218.1 |
Hbb-bs
|
hemoglobin, beta adult s chain |
chr6_+_113531675 | 3.61 |
ENSMUST00000036340.5
ENSMUST00000101051.2 |
Fancd2
|
Fanconi anemia, complementation group D2 |
chr1_+_129273344 | 3.60 |
ENSMUST00000073527.6
ENSMUST00000040311.7 |
Thsd7b
|
thrombospondin, type I, domain containing 7B |
chr7_-_99483645 | 3.60 |
ENSMUST00000107096.1
ENSMUST00000032998.6 |
Rps3
|
ribosomal protein S3 |
chr7_-_127042420 | 3.60 |
ENSMUST00000032915.6
|
Kif22
|
kinesin family member 22 |
chr11_+_24078111 | 3.59 |
ENSMUST00000109516.1
|
Bcl11a
|
B cell CLL/lymphoma 11A (zinc finger protein) |
chr14_-_47276790 | 3.59 |
ENSMUST00000111792.1
ENSMUST00000111791.1 ENSMUST00000111790.1 |
Wdhd1
|
WD repeat and HMG-box DNA binding protein 1 |
chr7_+_19282613 | 3.57 |
ENSMUST00000032559.9
|
Rtn2
|
reticulon 2 (Z-band associated protein) |
chr13_+_23746734 | 3.53 |
ENSMUST00000099703.2
|
Hist1h2bb
|
histone cluster 1, H2bb |
chr11_+_24078022 | 3.52 |
ENSMUST00000000881.6
|
Bcl11a
|
B cell CLL/lymphoma 11A (zinc finger protein) |
chr3_-_130730310 | 3.48 |
ENSMUST00000062601.7
|
Rpl34
|
ribosomal protein L34 |
chr14_-_20269162 | 3.47 |
ENSMUST00000024155.7
|
Kcnk16
|
potassium channel, subfamily K, member 16 |
chr14_-_76237353 | 3.46 |
ENSMUST00000095471.4
|
Rps2-ps6
|
ribosomal protein S2, pseudogene 6 |
chr10_+_127514939 | 3.44 |
ENSMUST00000035735.9
|
Ndufa4l2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
chr7_+_45554893 | 3.42 |
ENSMUST00000107752.3
|
Hsd17b14
|
hydroxysteroid (17-beta) dehydrogenase 14 |
chr8_-_71723308 | 3.41 |
ENSMUST00000125092.1
|
Fcho1
|
FCH domain only 1 |
chr2_+_131186942 | 3.40 |
ENSMUST00000028804.8
ENSMUST00000079857.8 |
Cdc25b
|
cell division cycle 25B |
chr7_-_118116171 | 3.39 |
ENSMUST00000131374.1
|
Rps15a
|
ribosomal protein S15A |
chr2_+_30416031 | 3.39 |
ENSMUST00000042055.3
|
Ppp2r4
|
protein phosphatase 2A, regulatory subunit B (PR 53) |
chr14_-_76556662 | 3.38 |
ENSMUST00000064517.7
|
Serp2
|
stress-associated endoplasmic reticulum protein family member 2 |
chr12_+_109452833 | 3.37 |
ENSMUST00000056110.8
|
Dlk1
|
delta-like 1 homolog (Drosophila) |
chr15_-_101694299 | 3.37 |
ENSMUST00000023788.6
|
Krt6a
|
keratin 6A |
chr2_+_30286383 | 3.36 |
ENSMUST00000064447.5
|
Nup188
|
nucleoporin 188 |
chrX_+_135993820 | 3.36 |
ENSMUST00000058119.7
|
Arxes2
|
adipocyte-related X-chromosome expressed sequence 2 |
chr3_+_96269695 | 3.33 |
ENSMUST00000051089.3
ENSMUST00000177113.1 |
Hist2h2bb
|
histone cluster 2, H2bb |
chr16_-_16869255 | 3.32 |
ENSMUST00000075017.4
|
Vpreb1
|
pre-B lymphocyte gene 1 |
chr6_+_124829582 | 3.31 |
ENSMUST00000024270.7
|
Cdca3
|
cell division cycle associated 3 |
chr8_+_71597648 | 3.30 |
ENSMUST00000143662.1
|
Fam129c
|
family with sequence similarity 129, member C |
chr3_-_95411176 | 3.29 |
ENSMUST00000177599.1
|
Gm5070
|
predicted gene 5070 |
chr7_-_118116128 | 3.28 |
ENSMUST00000128482.1
ENSMUST00000131840.1 |
Rps15a
|
ribosomal protein S15A |
chr9_+_108826320 | 3.22 |
ENSMUST00000024238.5
|
Celsr3
|
cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo homolog, Drosophila) |
chr18_-_62179948 | 3.22 |
ENSMUST00000053640.3
|
Adrb2
|
adrenergic receptor, beta 2 |
chr3_-_98339921 | 3.20 |
ENSMUST00000065793.5
|
Phgdh
|
3-phosphoglycerate dehydrogenase |
chr1_-_45503282 | 3.20 |
ENSMUST00000086430.4
|
Col5a2
|
collagen, type V, alpha 2 |
chr6_+_39420378 | 3.17 |
ENSMUST00000090237.2
|
Gm10244
|
predicted gene 10244 |
chr11_-_116077606 | 3.16 |
ENSMUST00000106450.1
|
Unc13d
|
unc-13 homolog D (C. elegans) |
chr14_-_89898466 | 3.16 |
ENSMUST00000081204.4
|
Gm10110
|
predicted gene 10110 |
chr10_+_75571522 | 3.13 |
ENSMUST00000143226.1
ENSMUST00000124259.1 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr8_-_84840627 | 3.13 |
ENSMUST00000003911.6
ENSMUST00000109761.2 ENSMUST00000128035.1 |
Rad23a
|
RAD23a homolog (S. cerevisiae) |
chr13_-_22041352 | 3.11 |
ENSMUST00000102977.2
|
Hist1h4i
|
histone cluster 1, H4i |
chr14_+_105681824 | 3.10 |
ENSMUST00000073238.6
|
Gm10076
|
predicted gene 10076 |
chr5_+_121220191 | 3.10 |
ENSMUST00000119892.2
ENSMUST00000042614.6 |
Gm15800
|
predicted gene 15800 |
chr14_-_54617993 | 3.08 |
ENSMUST00000022803.4
|
Psmb5
|
proteasome (prosome, macropain) subunit, beta type 5 |
chr15_-_79285502 | 3.07 |
ENSMUST00000165408.1
|
Baiap2l2
|
BAI1-associated protein 2-like 2 |
chr17_-_48451510 | 3.05 |
ENSMUST00000024794.5
|
Tspo2
|
translocator protein 2 |
chr13_+_23752267 | 3.05 |
ENSMUST00000091703.2
|
Hist1h3b
|
histone cluster 1, H3b |
chr16_-_22163299 | 3.05 |
ENSMUST00000100052.4
|
Igf2bp2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr13_-_97760588 | 3.04 |
ENSMUST00000074072.3
|
Gm10260
|
predicted gene 10260 |
chr6_+_124829540 | 3.04 |
ENSMUST00000150120.1
|
Cdca3
|
cell division cycle associated 3 |
chr1_-_132367879 | 3.03 |
ENSMUST00000142609.1
|
Tmcc2
|
transmembrane and coiled-coil domains 2 |
chr4_+_134102581 | 3.00 |
ENSMUST00000074690.4
ENSMUST00000070246.2 ENSMUST00000156750.1 |
Ubxn11
|
UBX domain protein 11 |
chr15_+_89334398 | 2.96 |
ENSMUST00000023282.2
|
Miox
|
myo-inositol oxygenase |
chr5_-_33936301 | 2.95 |
ENSMUST00000030993.6
|
Nelfa
|
negative elongation factor complex member A, Whsc2 |
chr11_+_32300069 | 2.95 |
ENSMUST00000020535.1
|
Hbq1a
|
hemoglobin, theta 1A |
chr13_-_23762378 | 2.94 |
ENSMUST00000091701.2
|
Hist1h3a
|
histone cluster 1, H3a |
chr9_-_108190352 | 2.91 |
ENSMUST00000035208.7
|
Bsn
|
bassoon |
chr12_-_34291092 | 2.90 |
ENSMUST00000166546.2
|
Gm18025
|
predicted gene, 18025 |
chr4_-_156200818 | 2.90 |
ENSMUST00000085425.4
|
Isg15
|
ISG15 ubiquitin-like modifier |
chr6_-_39420281 | 2.88 |
ENSMUST00000114822.1
ENSMUST00000051671.4 |
Mkrn1
|
makorin, ring finger protein, 1 |
chr7_+_4792874 | 2.88 |
ENSMUST00000032597.5
ENSMUST00000078432.4 |
Rpl28
|
ribosomal protein L28 |
chr19_-_42086338 | 2.88 |
ENSMUST00000051772.8
|
Morn4
|
MORN repeat containing 4 |
chr6_+_127233756 | 2.88 |
ENSMUST00000071458.3
|
Gm4968
|
predicted gene 4968 |
chr15_-_103251465 | 2.88 |
ENSMUST00000133600.1
ENSMUST00000134554.1 ENSMUST00000156927.1 ENSMUST00000149111.1 ENSMUST00000132836.1 |
Nfe2
|
nuclear factor, erythroid derived 2 |
chr7_-_133702515 | 2.87 |
ENSMUST00000153698.1
|
Uros
|
uroporphyrinogen III synthase |
chr12_+_109549157 | 2.84 |
ENSMUST00000128458.1
ENSMUST00000150851.1 |
Meg3
|
maternally expressed 3 |
chr5_+_76840597 | 2.84 |
ENSMUST00000120639.2
ENSMUST00000163347.1 ENSMUST00000121851.1 |
C530008M17Rik
|
RIKEN cDNA C530008M17 gene |
chr8_-_89187560 | 2.84 |
ENSMUST00000093326.2
|
Gm5356
|
predicted pseudogene 5356 |
chr1_+_191063001 | 2.83 |
ENSMUST00000076952.5
ENSMUST00000139340.1 ENSMUST00000078259.6 |
Nsl1
|
NSL1, MIND kinetochore complex component, homolog (S. cerevisiae) |
chr12_-_46818749 | 2.82 |
ENSMUST00000021438.6
|
Nova1
|
neuro-oncological ventral antigen 1 |
chr6_-_52226165 | 2.80 |
ENSMUST00000114425.2
|
Hoxa9
|
homeobox A9 |
chr11_+_117849223 | 2.80 |
ENSMUST00000081387.4
|
Birc5
|
baculoviral IAP repeat-containing 5 |
chr6_-_39420418 | 2.79 |
ENSMUST00000031985.6
|
Mkrn1
|
makorin, ring finger protein, 1 |
chr11_-_83286722 | 2.78 |
ENSMUST00000163961.2
|
Slfn14
|
schlafen family member 14 |
chr9_+_106203108 | 2.78 |
ENSMUST00000024047.5
|
Twf2
|
twinfilin, actin-binding protein, homolog 2 (Drosophila) |
chrX_+_56447965 | 2.78 |
ENSMUST00000079663.6
|
Gm2174
|
predicted gene 2174 |
chr17_-_27204357 | 2.77 |
ENSMUST00000055117.7
|
Lemd2
|
LEM domain containing 2 |
chr9_+_107950952 | 2.76 |
ENSMUST00000049348.3
|
Traip
|
TRAF-interacting protein |
chr18_+_82554463 | 2.75 |
ENSMUST00000062446.7
ENSMUST00000102812.4 ENSMUST00000075372.5 ENSMUST00000080658.4 ENSMUST00000152071.1 ENSMUST00000114674.3 ENSMUST00000142850.1 ENSMUST00000133193.1 ENSMUST00000123251.1 ENSMUST00000153478.1 ENSMUST00000132369.1 |
Mbp
|
myelin basic protein |
chr11_-_96005872 | 2.74 |
ENSMUST00000013559.2
|
Igf2bp1
|
insulin-like growth factor 2 mRNA binding protein 1 |
chr7_+_45715457 | 2.74 |
ENSMUST00000075178.3
|
Rpl18
|
ribosomal protein L18 |
chr3_+_68869563 | 2.73 |
ENSMUST00000054551.2
|
1110032F04Rik
|
RIKEN cDNA 1110032F04 gene |
chr2_+_29889720 | 2.72 |
ENSMUST00000113767.1
|
Odf2
|
outer dense fiber of sperm tails 2 |
chr2_+_155611175 | 2.72 |
ENSMUST00000092995.5
|
Myh7b
|
myosin, heavy chain 7B, cardiac muscle, beta |
chr5_+_90772435 | 2.71 |
ENSMUST00000031320.6
|
Pf4
|
platelet factor 4 |
chr1_+_93754899 | 2.71 |
ENSMUST00000027502.9
|
Atg4b
|
autophagy related 4B, cysteine peptidase |
chr7_-_133709051 | 2.68 |
ENSMUST00000124759.1
ENSMUST00000106144.1 |
Uros
|
uroporphyrinogen III synthase |
chr13_-_113100971 | 2.68 |
ENSMUST00000023897.5
|
Gzma
|
granzyme A |
chr16_+_33056453 | 2.66 |
ENSMUST00000078804.5
ENSMUST00000115079.1 |
Rpl35a
|
ribosomal protein L35A |
chr13_+_21717626 | 2.65 |
ENSMUST00000091754.2
|
Hist1h3h
|
histone cluster 1, H3h |
chr4_-_136956784 | 2.65 |
ENSMUST00000030420.8
|
Epha8
|
Eph receptor A8 |
chrX_+_8271381 | 2.65 |
ENSMUST00000033512.4
|
Slc38a5
|
solute carrier family 38, member 5 |
chr10_-_84533884 | 2.64 |
ENSMUST00000053871.3
|
Ckap4
|
cytoskeleton-associated protein 4 |
chr17_+_48232755 | 2.64 |
ENSMUST00000113251.3
ENSMUST00000048782.6 |
Trem1
|
triggering receptor expressed on myeloid cells 1 |
chr6_+_87778084 | 2.64 |
ENSMUST00000032133.3
|
Gp9
|
glycoprotein 9 (platelet) |
chr15_-_80083374 | 2.63 |
ENSMUST00000081650.7
|
Rpl3
|
ribosomal protein L3 |
chr2_-_35979624 | 2.63 |
ENSMUST00000028248.4
ENSMUST00000112976.2 |
Ttll11
|
tubulin tyrosine ligase-like family, member 11 |
chr10_+_79881023 | 2.63 |
ENSMUST00000166201.1
|
Prtn3
|
proteinase 3 |
chr16_+_33056499 | 2.62 |
ENSMUST00000115078.1
|
Rpl35a
|
ribosomal protein L35A |
chrX_-_142966709 | 2.61 |
ENSMUST00000041317.2
|
Ammecr1
|
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
chr8_+_83955507 | 2.61 |
ENSMUST00000005607.8
|
Asf1b
|
ASF1 anti-silencing function 1 homolog B (S. cerevisiae) |
chr13_-_21833575 | 2.60 |
ENSMUST00000081342.5
|
Hist1h2ap
|
histone cluster 1, H2ap |
chr18_+_36679575 | 2.59 |
ENSMUST00000050476.4
ENSMUST00000036158.6 |
Slc35a4
|
solute carrier family 35, member A4 |
chr17_+_29032664 | 2.59 |
ENSMUST00000130216.1
|
Srsf3
|
serine/arginine-rich splicing factor 3 |
chr11_+_24078173 | 2.58 |
ENSMUST00000109514.1
|
Bcl11a
|
B cell CLL/lymphoma 11A (zinc finger protein) |
chr12_+_109747903 | 2.56 |
ENSMUST00000183084.1
ENSMUST00000182300.1 |
Mirg
|
miRNA containing gene |
chr18_-_61259987 | 2.56 |
ENSMUST00000170335.2
|
Rps2-ps10
|
ribosomal protein S2, pseudogene 10 |
chr11_+_113649328 | 2.55 |
ENSMUST00000063776.7
|
Cog1
|
component of oligomeric golgi complex 1 |
chr9_+_57504012 | 2.54 |
ENSMUST00000080514.7
|
Rpp25
|
ribonuclease P/MRP 25 subunit |
chr11_-_59964936 | 2.54 |
ENSMUST00000062405.7
|
Rasd1
|
RAS, dexamethasone-induced 1 |
chr2_+_103970221 | 2.53 |
ENSMUST00000111140.2
ENSMUST00000111139.2 |
Lmo2
|
LIM domain only 2 |
chr10_-_117282262 | 2.53 |
ENSMUST00000092163.7
|
Lyz2
|
lysozyme 2 |
chr9_+_110419750 | 2.52 |
ENSMUST00000035061.6
|
Ngp
|
neutrophilic granule protein |
chr3_-_51396528 | 2.51 |
ENSMUST00000038154.5
|
Mgarp
|
mitochondria localized glutamic acid rich protein |
chr7_+_100494044 | 2.51 |
ENSMUST00000153287.1
|
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr1_+_170277376 | 2.51 |
ENSMUST00000179976.1
|
Sh2d1b1
|
SH2 domain protein 1B1 |
chr5_-_136135989 | 2.50 |
ENSMUST00000150406.1
ENSMUST00000006301.4 |
Lrwd1
|
leucine-rich repeats and WD repeat domain containing 1 |
chr11_+_46235460 | 2.50 |
ENSMUST00000060185.2
|
Fndc9
|
fibronectin type III domain containing 9 |
chr4_+_6191093 | 2.50 |
ENSMUST00000029907.5
|
Ubxn2b
|
UBX domain protein 2B |
chr11_+_32276400 | 2.49 |
ENSMUST00000020531.2
|
Hba-x
|
hemoglobin X, alpha-like embryonic chain in Hba complex |
chr17_+_36869567 | 2.48 |
ENSMUST00000060524.9
|
Trim10
|
tripartite motif-containing 10 |
chr17_+_28207778 | 2.48 |
ENSMUST00000002327.5
|
Def6
|
differentially expressed in FDCP 6 |
chr2_-_164356067 | 2.48 |
ENSMUST00000165980.1
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr7_-_133708958 | 2.47 |
ENSMUST00000106146.1
|
Uros
|
uroporphyrinogen III synthase |
chr6_-_115808736 | 2.46 |
ENSMUST00000081840.3
|
Rpl32
|
ribosomal protein L32 |
chr12_+_109743787 | 2.46 |
ENSMUST00000183068.1
|
Mirg
|
miRNA containing gene |
chr5_+_138161071 | 2.45 |
ENSMUST00000019638.8
ENSMUST00000110951.1 |
Cops6
|
COP9 (constitutive photomorphogenic) homolog, subunit 6 (Arabidopsis thaliana) |
chr6_+_38433913 | 2.45 |
ENSMUST00000160583.1
|
Ubn2
|
ubinuclein 2 |
chr16_+_36277145 | 2.44 |
ENSMUST00000042097.9
|
Stfa1
|
stefin A1 |
chr19_-_4305955 | 2.44 |
ENSMUST00000025791.5
|
Adrbk1
|
adrenergic receptor kinase, beta 1 |
chr5_-_114773488 | 2.43 |
ENSMUST00000178440.1
ENSMUST00000043283.7 ENSMUST00000112185.2 |
Git2
|
G protein-coupled receptor kinase-interactor 2 |
chr10_+_79879614 | 2.42 |
ENSMUST00000006679.8
|
Prtn3
|
proteinase 3 |
chr7_-_45830776 | 2.41 |
ENSMUST00000107723.2
ENSMUST00000131384.1 |
Grwd1
|
glutamate-rich WD repeat containing 1 |
chr14_+_11227511 | 2.41 |
ENSMUST00000080237.3
|
Rpl21-ps4
|
ribosomal protein L21, pseudogene 4 |
chr2_-_164356507 | 2.41 |
ENSMUST00000109367.3
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr13_-_21783391 | 2.39 |
ENSMUST00000099704.3
|
Hist1h3i
|
histone cluster 1, H3i |
chr9_-_44288535 | 2.39 |
ENSMUST00000161354.1
|
Abcg4
|
ATP-binding cassette, sub-family G (WHITE), member 4 |
chr7_+_25659153 | 2.39 |
ENSMUST00000079634.6
|
Exosc5
|
exosome component 5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 9.4 | GO:0070488 | neutrophil aggregation(GO:0070488) |
2.6 | 10.4 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
2.4 | 9.7 | GO:1904800 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
2.2 | 13.4 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
1.9 | 5.6 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
1.8 | 5.5 | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
1.4 | 46.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
1.4 | 6.8 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
1.3 | 5.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.3 | 3.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) neutrophil mediated killing of fungus(GO:0070947) |
1.2 | 1.2 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
1.2 | 4.9 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
1.2 | 3.7 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
1.2 | 2.4 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
1.2 | 3.5 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
1.1 | 9.0 | GO:0015671 | oxygen transport(GO:0015671) |
1.1 | 5.4 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
1.1 | 3.2 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
1.1 | 1.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
1.0 | 1.0 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.0 | 2.9 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
1.0 | 4.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.0 | 4.8 | GO:0051697 | protein delipidation(GO:0051697) |
1.0 | 2.9 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.9 | 11.3 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.9 | 2.8 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.9 | 2.7 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.9 | 4.6 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.9 | 8.1 | GO:0002432 | granuloma formation(GO:0002432) |
0.9 | 1.8 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.9 | 3.6 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.9 | 2.7 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.9 | 0.9 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.9 | 1.8 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.9 | 3.5 | GO:0031509 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
0.9 | 7.0 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.9 | 3.5 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.9 | 5.2 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.9 | 2.6 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.8 | 0.8 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.8 | 19.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.8 | 3.4 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
0.8 | 3.3 | GO:0031296 | B cell costimulation(GO:0031296) |
0.8 | 2.5 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.8 | 5.7 | GO:1904923 | regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
0.8 | 1.6 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.8 | 3.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.8 | 2.4 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.8 | 3.2 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.8 | 1.6 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.8 | 4.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.8 | 11.9 | GO:0015816 | glycine transport(GO:0015816) |
0.8 | 2.4 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.8 | 2.4 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
0.8 | 3.1 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
0.8 | 0.8 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.8 | 3.9 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.8 | 2.3 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.8 | 3.8 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.8 | 3.8 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.8 | 2.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.7 | 6.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.7 | 0.7 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
0.7 | 2.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.7 | 5.9 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.7 | 2.2 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.7 | 2.2 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.7 | 2.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.7 | 4.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.7 | 3.6 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
0.7 | 5.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.7 | 3.5 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.7 | 2.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.7 | 1.4 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.7 | 4.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.7 | 2.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.7 | 4.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.7 | 3.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.6 | 2.6 | GO:0035989 | tendon development(GO:0035989) |
0.6 | 1.9 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
0.6 | 1.9 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
0.6 | 3.8 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.6 | 3.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.6 | 1.9 | GO:0030221 | basophil differentiation(GO:0030221) |
0.6 | 3.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.6 | 2.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.6 | 1.3 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.6 | 2.5 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.6 | 4.4 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.6 | 5.0 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.6 | 3.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.6 | 4.9 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.6 | 4.3 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.6 | 0.6 | GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
0.6 | 2.4 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.6 | 1.8 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.6 | 1.7 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.6 | 1.7 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.6 | 1.7 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.6 | 3.3 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.6 | 1.1 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.5 | 4.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.5 | 3.8 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.5 | 2.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.5 | 2.7 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.5 | 9.5 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.5 | 1.6 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
0.5 | 1.6 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.5 | 32.9 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.5 | 1.0 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.5 | 2.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.5 | 2.0 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.5 | 4.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.5 | 2.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.5 | 2.0 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.5 | 1.5 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.5 | 0.5 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.5 | 6.0 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.5 | 7.0 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.5 | 1.5 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
0.5 | 3.5 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.5 | 1.5 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.5 | 2.9 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.5 | 1.9 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.5 | 1.4 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.5 | 1.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.5 | 1.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.5 | 2.4 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.5 | 1.4 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.5 | 1.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.5 | 3.7 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.5 | 3.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.5 | 0.9 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.5 | 0.5 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.5 | 4.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.5 | 5.0 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.5 | 1.4 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.4 | 1.3 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.4 | 1.8 | GO:0051586 | positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.4 | 2.7 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.4 | 1.3 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.4 | 2.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.4 | 0.4 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.4 | 14.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.4 | 1.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.4 | 3.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.4 | 2.6 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.4 | 2.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.4 | 1.3 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.4 | 3.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.4 | 1.7 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.4 | 0.9 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.4 | 0.4 | GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
0.4 | 1.3 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.4 | 1.7 | GO:0050960 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
0.4 | 0.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.4 | 1.3 | GO:0045004 | DNA replication proofreading(GO:0045004) |
0.4 | 1.7 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
0.4 | 0.4 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.4 | 2.9 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.4 | 1.7 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.4 | 2.5 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.4 | 0.8 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.4 | 1.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.4 | 3.7 | GO:1904396 | regulation of neuromuscular junction development(GO:1904396) |
0.4 | 0.8 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
0.4 | 0.8 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.4 | 2.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.4 | 2.9 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.4 | 2.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 1.2 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) negative regulation of histone phosphorylation(GO:0033128) |
0.4 | 1.2 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.4 | 2.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.4 | 2.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.4 | 2.4 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.4 | 1.6 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.4 | 0.8 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.4 | 1.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.4 | 3.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.4 | 4.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.4 | 1.6 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.4 | 1.2 | GO:0019043 | establishment of viral latency(GO:0019043) |
0.4 | 1.9 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.4 | 1.2 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.4 | 3.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.4 | 5.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.4 | 1.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.4 | 0.8 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.4 | 1.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 1.1 | GO:0009197 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.4 | 0.8 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.4 | 0.8 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.4 | 0.4 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
0.4 | 3.7 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 1.5 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.4 | 0.7 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.4 | 1.9 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.4 | 4.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.4 | 2.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.4 | 2.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 1.8 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) |
0.4 | 1.8 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.4 | 0.4 | GO:0051595 | response to methylglyoxal(GO:0051595) |
0.4 | 2.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 0.4 | GO:1904306 | positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
0.4 | 1.8 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.4 | 1.4 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.4 | 0.7 | GO:0061317 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.4 | 2.5 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.4 | 1.1 | GO:0055130 | D-serine catabolic process(GO:0036088) D-alanine family amino acid metabolic process(GO:0046144) D-alanine metabolic process(GO:0046436) D-alanine catabolic process(GO:0055130) |
0.4 | 0.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.4 | 1.4 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.4 | 0.7 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
0.4 | 1.1 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.4 | 2.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 1.0 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.3 | 0.7 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.3 | 1.0 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.3 | 2.4 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.3 | 3.4 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.3 | 1.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.3 | 5.5 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.3 | 2.7 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.3 | 2.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 0.7 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.3 | 3.1 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.3 | 1.4 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 0.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.3 | 2.3 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.3 | 1.0 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.3 | 1.3 | GO:1901376 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.3 | 3.7 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.3 | 1.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.3 | 1.3 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.3 | 1.6 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.3 | 0.7 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.3 | 1.0 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.3 | 1.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.3 | 1.6 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.3 | 4.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.3 | 1.6 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.3 | 6.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.3 | 0.3 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.3 | 4.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 2.6 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.3 | 0.6 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.3 | 1.3 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.3 | 0.9 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.3 | 1.3 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.3 | 0.9 | GO:0046032 | ADP catabolic process(GO:0046032) |
0.3 | 0.6 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 3.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.3 | 2.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 0.6 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.3 | 1.2 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.3 | 1.2 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.3 | 0.9 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.3 | 2.4 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 1.2 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.3 | 0.6 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.3 | 2.4 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.3 | 1.2 | GO:0061623 | glycolytic process from galactose(GO:0061623) |
0.3 | 4.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.3 | 1.8 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.3 | 1.5 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.3 | 7.3 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.3 | 0.6 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.3 | 0.3 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.3 | 1.7 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.3 | 1.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.3 | 2.3 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.3 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.3 | 0.9 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.3 | 1.7 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.3 | 2.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.3 | 1.4 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.3 | 0.6 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.3 | 3.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.3 | 0.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.3 | 1.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.3 | 0.3 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.3 | 3.9 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.3 | 4.7 | GO:0000338 | protein deneddylation(GO:0000338) |
0.3 | 2.5 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.3 | 0.8 | GO:0043519 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.3 | 2.5 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.3 | 3.8 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.3 | 0.5 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.3 | 11.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.3 | 0.3 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.3 | 2.4 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.3 | 1.9 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.3 | 0.8 | GO:0044828 | modulation by host of viral genome replication(GO:0044827) negative regulation by host of viral genome replication(GO:0044828) |
0.3 | 0.8 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.3 | 0.8 | GO:1902220 | positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902220) |
0.3 | 0.3 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.3 | 0.8 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
0.3 | 1.6 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.3 | 3.9 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.3 | 1.0 | GO:0015793 | glycerol transport(GO:0015793) renal water absorption(GO:0070295) |
0.3 | 6.7 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.3 | 2.1 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 0.8 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.3 | 5.6 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.3 | 2.8 | GO:0090196 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.3 | 4.8 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.3 | 0.3 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.2 | 1.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 1.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.2 | 1.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 2.7 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.2 | 0.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.7 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.2 | 0.7 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.2 | 1.0 | GO:0033377 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
0.2 | 1.7 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.2 | 1.0 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 0.7 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 0.5 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.2 | 0.7 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.2 | 0.5 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.2 | 4.4 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.2 | 1.0 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.2 | 0.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 0.5 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 1.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 1.7 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 6.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 1.2 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.2 | 0.9 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.2 | 0.5 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 0.7 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 1.9 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 1.4 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.2 | 2.5 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.2 | 2.1 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.2 | 0.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 0.9 | GO:0018158 | protein oxidation(GO:0018158) |
0.2 | 5.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.2 | 1.4 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
0.2 | 2.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.5 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.2 | 0.9 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 23.0 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.2 | 0.9 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.2 | 0.7 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 | 1.1 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.2 | 0.2 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.4 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.2 | 0.2 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.2 | 1.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 0.4 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.2 | 0.7 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.2 | 1.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 1.3 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.2 | 0.4 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.2 | 0.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 2.2 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.2 | 0.4 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.2 | 1.3 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.2 | 2.4 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.2 | 1.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.2 | 0.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.2 | 0.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.4 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.2 | 1.3 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.2 | 0.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.2 | 1.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.2 | GO:0019046 | release from viral latency(GO:0019046) |
0.2 | 0.6 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.2 | 1.0 | GO:0090290 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.2 | 4.5 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 1.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.2 | 1.0 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.2 | 0.6 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 1.8 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 5.0 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.2 | 6.4 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 1.8 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.2 | 1.2 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 1.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 1.8 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.8 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.2 | 2.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 1.8 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 1.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 2.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 0.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 1.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.2 | 1.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 0.4 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.2 | 2.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 2.9 | GO:0015809 | arginine transport(GO:0015809) |
0.2 | 0.9 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.6 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.2 | 1.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 0.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 1.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 0.4 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 1.7 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 0.6 | GO:1990167 | protein K29-linked deubiquitination(GO:0035523) protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 0.4 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.2 | 1.5 | GO:0043486 | histone exchange(GO:0043486) |
0.2 | 0.2 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
0.2 | 2.4 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.2 | 3.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.2 | 2.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.5 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.2 | 0.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 1.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 2.0 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.2 | 0.5 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.2 | 1.3 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 1.5 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.2 | 12.0 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 1.1 | GO:1901881 | positive regulation of actin filament depolymerization(GO:0030836) positive regulation of protein depolymerization(GO:1901881) |
0.2 | 1.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 1.4 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.2 | 0.9 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.2 | 0.9 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.2 | 1.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.2 | 1.4 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.2 | 2.3 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.2 | 0.9 | GO:0070472 | regulation of uterine smooth muscle contraction(GO:0070472) positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.2 | 1.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.2 | 2.8 | GO:0006298 | mismatch repair(GO:0006298) |
0.2 | 0.5 | GO:0050929 | chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
0.2 | 0.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.2 | 2.9 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.2 | 1.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.2 | 1.9 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 3.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 0.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.8 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.2 | 0.2 | GO:1903296 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
0.2 | 3.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.8 | GO:0044805 | late nucleophagy(GO:0044805) |
0.2 | 1.3 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 0.8 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 0.5 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 1.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 0.5 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.2 | 0.6 | GO:0035799 | ureter maturation(GO:0035799) |
0.2 | 0.6 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) negative regulation of nodal signaling pathway(GO:1900108) |
0.2 | 0.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.6 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 5.3 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 0.2 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.2 | 0.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.2 | 0.5 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 0.3 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.2 | 0.8 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.2 | 0.6 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.2 | 0.9 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.2 | 0.5 | GO:0033189 | response to vitamin A(GO:0033189) |
0.2 | 1.3 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.2 | 0.6 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.9 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.2 | 2.8 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 3.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 0.9 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 0.6 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 4.9 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.2 | 1.8 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.2 | 1.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 1.5 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 0.9 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 5.7 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.2 | 2.6 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.2 | 0.9 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 2.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 1.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 1.5 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 1.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.4 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
0.1 | 1.2 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.7 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.1 | 17.6 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.1 | 0.9 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.6 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.4 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.6 | GO:0021586 | pons maturation(GO:0021586) |
0.1 | 1.0 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 1.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.4 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.1 | 0.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 1.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.7 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.1 | 0.7 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.7 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 3.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.6 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 1.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 2.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 1.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.3 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.1 | 0.7 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 0.4 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.1 | 1.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 1.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.3 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.1 | 0.1 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.3 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.4 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 0.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 1.1 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.5 | GO:0042125 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.1 | 0.7 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.4 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.1 | 0.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.4 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 0.4 | GO:0015801 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.1 | 0.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.4 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.1 | 1.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 1.0 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.8 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.8 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.3 | GO:0010286 | heat acclimation(GO:0010286) |
0.1 | 0.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 5.0 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.9 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 2.6 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.3 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 4.9 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 2.1 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 2.1 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.8 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 2.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.5 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.1 | 1.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.3 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.8 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.1 | 0.4 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 7.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 1.3 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 0.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 5.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 1.7 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.7 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 1.2 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 2.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.8 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
0.1 | 4.7 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.1 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.7 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 3.9 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.9 | GO:0043585 | nose morphogenesis(GO:0043585) alveolar primary septum development(GO:0061143) |
0.1 | 1.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 1.5 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.3 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.1 | 0.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 1.7 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.6 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 1.1 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.3 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.1 | 0.5 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 1.1 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.7 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.4 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 1.3 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 | 1.0 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.4 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.8 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.6 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.6 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.4 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.1 | 0.3 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.8 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.3 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.1 | 0.2 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.1 | 3.6 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.3 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 1.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.6 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 1.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.4 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.4 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.7 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.1 | 0.3 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.1 | 0.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 2.6 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 1.4 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.8 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.4 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.1 | 0.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 3.0 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
0.1 | 0.4 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.1 | 1.0 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 1.8 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.5 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 0.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 1.4 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.1 | 0.2 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.1 | 1.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 1.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.4 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.1 | GO:1990773 | regulation of matrix metallopeptidase secretion(GO:1904464) matrix metallopeptidase secretion(GO:1990773) |
0.1 | 0.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 1.0 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.1 | 1.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 1.9 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.1 | 0.6 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.1 | 0.5 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.5 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.1 | 0.5 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 11.2 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.1 | 0.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.1 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 1.7 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.2 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
0.1 | 0.5 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.1 | 0.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.6 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 1.3 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 1.1 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.1 | 0.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.1 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 2.7 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.1 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.1 | 0.2 | GO:1903094 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) regulation of ubiquitin-specific protease activity(GO:2000152) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.1 | 0.6 | GO:0015862 | uridine transport(GO:0015862) |
0.1 | 0.1 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 3.7 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 1.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 0.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 1.4 | GO:0048821 | erythrocyte development(GO:0048821) |
0.1 | 0.3 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
0.1 | 0.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 1.0 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.3 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 0.3 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 0.7 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 1.0 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.1 | 0.2 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.1 | 0.3 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.5 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 | 0.2 | GO:1902592 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.1 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.6 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 0.9 | GO:0048665 | neuron fate specification(GO:0048665) |
0.1 | 0.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.4 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.4 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.2 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 0.3 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 1.0 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 0.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.8 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.4 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 2.9 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 0.8 | GO:0086067 | AV node cell to bundle of His cell communication(GO:0086067) |
0.1 | 0.1 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.2 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.4 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.2 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.1 | 0.1 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.1 | 0.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 1.1 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 2.4 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.3 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.2 | GO:1905171 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.1 | 0.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.2 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.3 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.1 | 0.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 1.3 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 | 1.8 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.4 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.1 | GO:0043243 | positive regulation of protein complex disassembly(GO:0043243) |
0.1 | 0.3 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.1 | 0.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 0.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.3 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.1 | 0.7 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.1 | 2.0 | GO:0038202 | TORC1 signaling(GO:0038202) |
0.1 | 0.7 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.4 | GO:1901739 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.5 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.3 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 0.2 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.4 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 1.4 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.4 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 3.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 2.0 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.6 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 0.2 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.1 | 0.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 0.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.1 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.2 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.1 | 0.4 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.2 | GO:1902477 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.1 | 0.1 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.1 | 0.1 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 3.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.9 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 1.2 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.4 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 0.5 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.2 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.1 | 0.8 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.1 | GO:0072014 | proximal tubule development(GO:0072014) |
0.1 | 0.6 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.6 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.4 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 1.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.6 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.6 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.2 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.2 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.1 | GO:0097274 | urea homeostasis(GO:0097274) |
0.0 | 0.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.0 | 0.6 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.0 | 0.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 0.1 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.0 | 0.1 | GO:0031497 | chromatin assembly(GO:0031497) |
0.0 | 0.1 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.0 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.2 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.0 | 0.5 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.3 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.5 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.1 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.1 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.3 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.0 | 1.1 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.5 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.2 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.0 | 0.5 | GO:0032925 | regulation of activin receptor signaling pathway(GO:0032925) |
0.0 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.0 | 0.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.0 | 0.6 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.4 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.3 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
0.0 | 0.8 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 0.4 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.2 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.0 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 1.4 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 1.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.3 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.0 | 0.0 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.0 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.4 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.1 | GO:0051030 | snRNA transport(GO:0051030) |
0.0 | 0.7 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.0 | 0.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.4 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.0 | 0.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.4 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.5 | GO:0017145 | stem cell division(GO:0017145) |
0.0 | 0.4 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.0 | 0.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.0 | 0.1 | GO:0019085 | early viral transcription(GO:0019085) late viral transcription(GO:0019086) |
0.0 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 1.4 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.1 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.0 | 0.1 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.0 | 0.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.0 | 0.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.1 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.0 | 0.3 | GO:0032924 | activin receptor signaling pathway(GO:0032924) |
0.0 | 0.1 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.0 | 0.2 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.1 | GO:0045113 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.1 | GO:0018900 | dichloromethane metabolic process(GO:0018900) |
0.0 | 0.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.1 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.0 | 0.1 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.3 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.0 | 0.2 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.0 | 0.1 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.0 | 0.3 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.4 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.0 | 0.5 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.0 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.1 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.0 | 0.3 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.1 | GO:0090186 | regulation of pancreatic juice secretion(GO:0090186) |
0.0 | 0.9 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.0 | 0.2 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.5 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.0 | 0.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.0 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.2 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.2 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.4 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
0.0 | 0.1 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
0.0 | 0.9 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.6 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.4 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.0 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.0 | 0.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.0 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.1 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.0 | 0.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.0 | 1.0 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.0 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.0 | 0.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.9 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.2 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.1 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.0 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.0 | 0.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 0.1 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.0 | 0.1 | GO:0046333 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.0 | 0.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.0 | 0.1 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.0 | 0.0 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) |
0.0 | 0.3 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.0 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.0 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.0 | 1.8 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.0 | 0.0 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.0 | 0.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.2 | GO:0039528 | cytoplasmic pattern recognition receptor signaling pathway in response to virus(GO:0039528) RIG-I signaling pathway(GO:0039529) |
0.0 | 0.0 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.0 | 0.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.1 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.0 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.0 | 0.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.0 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 21.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
2.3 | 13.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.6 | 4.9 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
1.3 | 1.3 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
1.3 | 5.0 | GO:0014802 | terminal cisterna(GO:0014802) |
1.2 | 2.5 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
1.2 | 8.6 | GO:0005638 | lamin filament(GO:0005638) |
1.2 | 6.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.2 | 45.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.2 | 9.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.1 | 3.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.0 | 2.9 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
0.9 | 3.8 | GO:0032021 | NELF complex(GO:0032021) |
0.9 | 75.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.9 | 2.8 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.9 | 45.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.9 | 3.7 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.9 | 9.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.9 | 4.4 | GO:0034709 | methylosome(GO:0034709) |
0.9 | 5.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.8 | 9.5 | GO:0005687 | U4 snRNP(GO:0005687) |
0.6 | 7.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.6 | 3.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.6 | 27.6 | GO:0000786 | nucleosome(GO:0000786) |
0.6 | 1.9 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.6 | 1.9 | GO:0035101 | FACT complex(GO:0035101) |
0.6 | 3.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.6 | 2.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.6 | 1.7 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.6 | 2.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.5 | 0.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.5 | 1.6 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
0.5 | 1.6 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
0.5 | 1.6 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.5 | 2.6 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.5 | 3.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.5 | 3.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.5 | 2.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.5 | 1.5 | GO:1990423 | RZZ complex(GO:1990423) |
0.5 | 4.0 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 1.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.5 | 4.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.5 | 2.9 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.5 | 3.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.5 | 7.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.5 | 6.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.5 | 2.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.4 | 4.9 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.4 | 1.7 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.4 | 4.6 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 1.7 | GO:0044393 | microspike(GO:0044393) |
0.4 | 2.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 4.1 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.4 | 2.0 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.4 | 6.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.4 | 2.4 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.4 | 2.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.4 | 10.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 1.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.4 | 1.9 | GO:1990745 | EARP complex(GO:1990745) |
0.4 | 4.6 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 1.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.4 | 1.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 4.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.4 | 3.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.4 | 3.0 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.4 | 3.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.4 | 1.1 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.3 | 1.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 1.7 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.3 | 1.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 1.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.3 | 1.7 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.3 | 4.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.3 | 2.3 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 0.7 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.3 | 7.8 | GO:0005839 | proteasome core complex(GO:0005839) |
0.3 | 2.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 1.3 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
0.3 | 1.3 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.3 | 4.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 0.9 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.3 | 7.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.3 | 5.9 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 1.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.3 | 2.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 4.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.3 | 6.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.3 | 6.9 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.3 | 0.9 | GO:0000805 | X chromosome(GO:0000805) |
0.3 | 6.8 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 0.9 | GO:0034657 | GID complex(GO:0034657) |
0.3 | 1.5 | GO:1990037 | Lewy body core(GO:1990037) |
0.3 | 2.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 1.7 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 3.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 1.4 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.3 | 0.8 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.3 | 3.6 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 1.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 1.1 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.3 | 3.0 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 1.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.3 | 8.9 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.3 | 1.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.3 | 0.8 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
0.3 | 0.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 2.9 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 1.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 1.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 1.8 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.3 | 1.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 1.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 0.5 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.3 | 1.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 6.1 | GO:0001741 | XY body(GO:0001741) |
0.2 | 1.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.2 | 1.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 2.4 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 1.9 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 13.6 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.2 | 4.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 1.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.2 | 0.9 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.2 | 3.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 1.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 4.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 0.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 2.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 9.0 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 0.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 2.4 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 1.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 1.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 0.8 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 1.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 1.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 2.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 3.5 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.2 | 0.6 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
0.2 | 0.6 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.2 | 4.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 2.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 3.1 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 1.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 2.9 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.2 | 1.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 5.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 0.6 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 0.6 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.2 | 1.8 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 0.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 0.7 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 2.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 0.5 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.2 | 0.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 15.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 6.9 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 0.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 3.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 2.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 0.7 | GO:0097386 | glial cell projection(GO:0097386) |
0.2 | 3.5 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 4.0 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.2 | 1.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 1.0 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.2 | 0.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 1.3 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 1.0 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.2 | 0.6 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 2.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 1.4 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 1.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.1 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.1 | 0.6 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.4 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.1 | 3.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.4 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 1.3 | GO:0001939 | female pronucleus(GO:0001939) |
0.1 | 0.7 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.5 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 5.5 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.3 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.1 | 0.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 6.0 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 1.5 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.4 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.1 | 0.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 1.2 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 5.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 0.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 1.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 1.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 1.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.6 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.2 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 4.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 1.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 1.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 1.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 1.4 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 1.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 1.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 1.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.3 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.1 | 0.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 1.0 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 0.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 6.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 1.0 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.1 | GO:0030681 | ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 9.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.9 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.8 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 3.1 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.3 | GO:0030690 | Noc complex(GO:0030689) Noc1p-Noc2p complex(GO:0030690) |
0.1 | 0.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 2.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 4.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 1.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 2.6 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 2.0 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 5.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.2 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 0.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.3 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.5 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.2 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.6 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 4.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.4 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.2 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.1 | 1.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.4 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.1 | 2.5 | GO:0030684 | preribosome(GO:0030684) |
0.1 | 1.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.3 | GO:0097361 | CIA complex(GO:0097361) |
0.1 | 2.9 | GO:0031430 | M band(GO:0031430) |
0.1 | 2.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 1.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.3 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.3 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.1 | 0.3 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.1 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.1 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 3.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.9 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 1.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 1.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 2.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 1.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 2.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 1.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 5.6 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.6 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.5 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 0.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 1.3 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.1 | 1.3 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 2.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.7 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 1.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.4 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 1.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.1 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.4 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.1 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.0 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.5 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.0 | 0.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 2.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 2.8 | GO:0000792 | heterochromatin(GO:0000792) |
0.0 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.2 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.0 | 0.2 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.4 | GO:0044754 | autolysosome(GO:0044754) |
0.0 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.1 | GO:0071920 | cleavage body(GO:0071920) |
0.0 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0060473 | cortical granule(GO:0060473) |
0.0 | 0.2 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 0.5 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 4.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.4 | GO:0031672 | A band(GO:0031672) |
0.0 | 1.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.8 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.4 | GO:0098800 | inner mitochondrial membrane protein complex(GO:0098800) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 2.1 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.1 | GO:0090537 | CERF complex(GO:0090537) |
0.0 | 2.2 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.1 | GO:0008623 | CHRAC(GO:0008623) |
0.0 | 0.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.4 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 3.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.1 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.0 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.7 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 2.7 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 1.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.1 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 3.4 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.2 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 8.9 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.0 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.0 | 0.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 13.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.9 | 11.4 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
1.6 | 4.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.5 | 11.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.3 | 4.0 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
1.2 | 3.5 | GO:0045352 | interleukin-1, Type II receptor binding(GO:0005151) interleukin-1 Type I receptor antagonist activity(GO:0045352) interleukin-1 Type II receptor antagonist activity(GO:0045353) |
1.1 | 5.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.1 | 5.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.0 | 2.1 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.0 | 3.9 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
1.0 | 3.9 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.9 | 3.8 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.9 | 2.8 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.9 | 4.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.9 | 2.7 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.9 | 3.4 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.8 | 11.7 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.8 | 1.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.8 | 3.2 | GO:0004488 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.8 | 2.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.8 | 2.4 | GO:0036004 | GAF domain binding(GO:0036004) |
0.7 | 2.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.7 | 8.8 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.7 | 7.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.7 | 4.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.7 | 5.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.7 | 9.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.7 | 2.1 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.7 | 2.1 | GO:0001002 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.7 | 117.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.7 | 5.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.7 | 3.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.6 | 32.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.6 | 1.9 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.6 | 2.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.6 | 1.9 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.6 | 3.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) D-glucose transmembrane transporter activity(GO:0055056) |
0.6 | 2.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.6 | 1.9 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.6 | 2.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.6 | 3.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.6 | 2.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.6 | 1.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.6 | 1.7 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.6 | 4.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.5 | 2.2 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.5 | 3.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.5 | 3.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.5 | 2.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.5 | 2.7 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.5 | 1.6 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.5 | 3.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.5 | 3.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.5 | 2.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.5 | 2.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.5 | 4.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.5 | 1.5 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.5 | 4.0 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.5 | 3.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.5 | 4.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.5 | 3.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.5 | 1.5 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
0.5 | 4.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.5 | 2.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.5 | 4.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.5 | 2.3 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.5 | 2.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 3.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 4.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.4 | 1.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.4 | 1.3 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
0.4 | 2.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.4 | 5.1 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.4 | 2.5 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.4 | 1.3 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.4 | 1.7 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.4 | 1.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.4 | 2.0 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 4.4 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.4 | 2.4 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.4 | 1.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.4 | 1.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 4.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.4 | 1.5 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.4 | 1.2 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.4 | 5.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.4 | 5.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.4 | 1.1 | GO:0050145 | uridylate kinase activity(GO:0009041) nucleoside phosphate kinase activity(GO:0050145) |
0.4 | 17.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.4 | 2.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.4 | 6.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.4 | 1.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.4 | 1.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 1.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.4 | 1.8 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.4 | 0.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.4 | 1.8 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.4 | 3.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 7.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.4 | 0.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.4 | 0.4 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.3 | 3.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 1.7 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 2.4 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.3 | 1.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.3 | 2.0 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 1.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 1.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.3 | 1.0 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.3 | 0.9 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 0.9 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 7.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 3.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.3 | 0.9 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.3 | 1.2 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.3 | 1.5 | GO:0043532 | angiostatin binding(GO:0043532) |
0.3 | 1.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 1.5 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 0.6 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.3 | 1.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 5.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 2.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 0.9 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.3 | 3.2 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.3 | 11.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 6.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 0.9 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.3 | 6.9 | GO:0008143 | poly(A) binding(GO:0008143) |
0.3 | 1.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 0.9 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.3 | 1.4 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.3 | 5.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 1.7 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.3 | 1.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.3 | 0.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 5.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 1.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.3 | 0.8 | GO:0034188 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.3 | 0.3 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.3 | 1.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.3 | 3.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 0.8 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.3 | 0.8 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.3 | 0.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 1.1 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.3 | 6.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.3 | 1.3 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 2.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 1.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 0.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 1.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.3 | 1.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 1.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.3 | 1.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.3 | 7.1 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.3 | 3.0 | GO:0031386 | protein tag(GO:0031386) |
0.3 | 9.6 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.3 | 2.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 0.8 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 2.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 1.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 1.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 1.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 2.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 1.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 0.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 1.9 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.2 | 1.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 0.7 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.2 | 0.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 1.4 | GO:0035240 | dopamine binding(GO:0035240) |
0.2 | 0.7 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 0.9 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.2 | 0.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 0.9 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.2 | 1.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 1.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 0.9 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.2 | 8.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 1.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 1.8 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 0.7 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
0.2 | 4.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 2.9 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 0.7 | GO:0048030 | disaccharide binding(GO:0048030) |
0.2 | 0.2 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.2 | 2.6 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 1.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 1.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 1.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 1.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 0.6 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.2 | 4.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 1.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 1.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.2 | 2.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 0.6 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 2.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 1.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 4.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 1.0 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 1.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.2 | 2.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 1.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 0.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 0.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 3.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 0.6 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.2 | 0.6 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.2 | 1.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 3.6 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.2 | 0.8 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.2 | 1.2 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 0.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 2.9 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 20.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 1.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 1.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 0.8 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.2 | 0.8 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 1.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 0.6 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.2 | 0.6 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.2 | 4.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 1.9 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 0.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 1.1 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.2 | 2.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 0.6 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.2 | 1.7 | GO:0008443 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) phosphofructokinase activity(GO:0008443) |
0.2 | 1.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.5 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
0.2 | 1.6 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 0.9 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 2.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 3.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 1.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.2 | 1.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 3.0 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.2 | 5.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.5 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.2 | 1.9 | GO:0051870 | methotrexate binding(GO:0051870) |
0.2 | 2.0 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 0.7 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.2 | 0.5 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.2 | 1.2 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.2 | 1.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 4.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 2.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 1.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.2 | 1.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 1.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 3.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 1.9 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 6.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 1.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 0.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 0.8 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.2 | 1.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.5 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.2 | 3.9 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 0.8 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 5.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.2 | 0.5 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 2.1 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.2 | 0.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 1.2 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.5 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.2 | 3.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 1.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 1.0 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 5.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.9 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.1 | 0.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 3.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.4 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 1.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 1.5 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 1.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 2.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.8 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 3.9 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.1 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.4 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.9 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.6 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.1 | 1.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 1.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.6 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 9.5 | GO:0019209 | kinase activator activity(GO:0019209) |
0.1 | 0.6 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 1.0 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.1 | 0.3 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.1 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 1.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 1.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 1.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 3.3 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.8 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.5 | GO:0051998 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.1 | 1.4 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 1.8 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 1.4 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 1.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 10.0 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 0.6 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.3 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.1 | 0.3 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.3 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
0.1 | 0.1 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 1.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 11.6 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 8.1 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 0.3 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.1 | 0.3 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.4 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 1.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.3 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 1.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.3 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.1 | 1.7 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 5.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.7 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 1.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.5 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 2.9 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.5 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 2.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.4 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 0.5 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.4 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.1 | 0.3 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 0.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 1.4 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) |
0.1 | 6.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.8 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.6 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.4 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 0.5 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.1 | 2.6 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 1.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 8.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.3 | GO:0046870 | mercury ion binding(GO:0045340) cadmium ion binding(GO:0046870) |
0.1 | 0.4 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 3.2 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 1.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 2.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 1.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.4 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.9 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 2.5 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 2.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.4 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 1.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 2.4 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.1 | 0.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 2.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 1.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 3.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 3.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 2.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 4.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 1.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.2 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.1 | 0.2 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.1 | 0.1 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 1.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 1.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 3.1 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 2.5 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 1.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 5.2 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 2.9 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 0.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.4 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 1.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 7.6 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 1.0 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 1.8 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.0 | 0.5 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 2.2 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.8 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.1 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.0 | 0.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.0 | 0.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 1.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 2.9 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.4 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.0 | 1.3 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.9 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 0.1 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
0.0 | 0.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.0 | 0.5 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 1.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 0.1 | GO:0070002 | glutamic-type peptidase activity(GO:0070002) |
0.0 | 0.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.4 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 1.0 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 1.3 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 1.4 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.1 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.0 | 0.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.0 | 0.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.2 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.1 | GO:0016824 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.0 | 0.1 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.6 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 0.4 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
0.0 | 0.9 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.7 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 1.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.0 | 3.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 1.3 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 2.3 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.1 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 2.3 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:1904315 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 0.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.0 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.9 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 1.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.6 | 26.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.4 | 0.9 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 14.5 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 20.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 0.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 2.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 4.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 2.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 8.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 4.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 9.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 10.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 0.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 9.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 4.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 1.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 2.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 6.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 5.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 1.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 2.8 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 13.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 5.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 18.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 3.7 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 0.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 6.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 4.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 4.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 3.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 6.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 2.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 3.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 7.6 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 3.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 6.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 2.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 2.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 0.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 2.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 3.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 7.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.8 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 3.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 3.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.9 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 2.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 4.2 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 4.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 1.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 2.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 5.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 2.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.8 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 2.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 1.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 1.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 5.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.5 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 64.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.2 | 126.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.1 | 4.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.8 | 4.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.7 | 7.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.7 | 9.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.6 | 8.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.6 | 14.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.6 | 5.9 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.6 | 5.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.6 | 11.6 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.5 | 4.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.5 | 1.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 16.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.5 | 5.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.4 | 8.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 10.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.4 | 4.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 20.8 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.4 | 1.5 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.4 | 2.6 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.3 | 9.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 1.0 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.3 | 8.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 9.9 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 4.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 0.6 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.3 | 12.4 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.3 | 10.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 21.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 5.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.3 | 4.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 0.6 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.3 | 1.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 2.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.3 | 2.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 6.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 6.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 7.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.2 | 1.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 1.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 4.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 0.9 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.2 | 4.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 5.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 5.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 8.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 7.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 3.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 6.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 13.6 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.2 | 1.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.2 | 1.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 2.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 10.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 5.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 2.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 4.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 2.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 1.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 2.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 6.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 2.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 6.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 4.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.2 | 2.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 0.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 3.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 1.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 7.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 0.6 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.2 | 3.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.0 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 1.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 5.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.9 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 6.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 10.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 6.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 5.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.3 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 5.5 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 0.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 8.9 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 0.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 3.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 2.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 0.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 7.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.4 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 4.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 1.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 2.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 1.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 2.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.7 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 0.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 3.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 2.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 1.9 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.5 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 1.3 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 0.7 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.8 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 0.6 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 4.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.2 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 1.8 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 1.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 1.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 1.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 1.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.2 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.0 | 0.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 1.6 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 0.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 5.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 1.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 1.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.5 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 2.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.3 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 3.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |